Cytokinetics Inc

Market cap: $6,833,001,525

Exchange: NAS

Sector: Health Technology

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

STOCK PRICE CHART

Key Statistics

Company Name

Cytokinetics Inc

Average Volume (10 days)

1,109,862

Average Volume (30 days)

1,046,754

Moving Average (50 days)

$68.51

Moving Average (200 days)

$59.69

Ex-Divided Date

n/a

Dividend Yield

P/E Ratio

-12.9845

Market Cap

6,833,001,525

Shares Outstanding

104,576,087

52-Week High Split Adjust Only

110.25

52-Week Low Split Adjust Only

25.98

Employee Count

447

Beta

1.291

Next Earnings Date

2024-05-08

TTM Dividend Rate Per Share

Price Changes

Past 5 days

-0.03%

Past 30 days

-0.08%

Past 3 months

-0.21%

Past 6 months

1.02%

Past year

0.76%

Past 2 years

0.93%

Past 5 years

6.11%

Max % Change

0.46%

PEER GROUP COMPARATIVE PERFORMANCE

Name	Ticker	Price/Sales (ttm)	Price/Book (ttm)	Forward P/E	PEG Ratio	EV/Revenue
Cytokinetics Inc	CYTK	26.75	23.08	-8.4	26.75	21.82
Peer Avg	N/A	2.51	2.91	10.9	2.51	2.80
AMGEN Inc.	AMGN	5.43	14.65	14.6	5.43	6.31
Array Technologies Inc	ARRY	n/a	n/a	37.6	n/a	n/a
Ligand Pharmaceuticals, Inc. - Class B	LGND	9.40	2.63	19.1	9.40	9.49
ARCA biopharma Inc	ABIO	n/a	n/a	n/a	n/a	n/a
Trevena Inc	TRVN	n/a	n/a	-5.5	n/a	n/a
Acorda Therapeutics Inc	ACOR	0.23	0.17	-0.5	0.23	1.01